Pearson PLC (PSON) — Investment Research Note

Executive summary

Pearson is the world's largest lifelong-learning company, monetising proprietary content and assessment IP across five divisions (Assessment & Qualifications, Virtual Learning, Higher Education, English Language Learning, Enterprise Learning & Skills). Under CEO Omar Abbosh, the group has moved from post-2015 decline to a phase of steady mid-single-digit organic growth with expanding margins, a share buyback and modest re-leveraging — H1 2026 revenue +4%, adjusted operating profit +14% with 140bps margin expansion to 15.5% 2026-07 H1 results. The single most important valuation issue is whether the market is already paying for the "AI-receiver" narrative around VUE, Enterprise and Credly given the shares have re-rated ~30% over the last year.

Fair value estimate

• Methodology: Forward P/E cross-checked with EV/EBIT and DCF. FY26 guidance midpoint is £662m adjusted operating profit; after ~£80m adjusted finance costs and 25% tax, adjusted net income ~£437m. Post-£350m buyback (35m shares cancelled at avg 998p) share count is ~600m, giving FY26e adjusted EPS of ~73p and FY27e (assuming 40bps margin gain, mid-single-digit revenue) ~80p.
• Fair value range: 1,150p – 1,400p per share, implied on 16–19x FY26e EPS.
• Implied market cap range: £6,900m – £8,400m (mid ~£7,650m).
• Vs. current £7,361m: essentially fair value; central case ~4% upside, wide-range ~-11% to +8%.
• DCF cross-check: FCF ~£500m growing 4-5% with 2.5% terminal, WACC 8% → equity value ~£7.5–8.0bn, corroborates the range.

Sector context

Confirmed Consumer Discretionary / Media (ICB) but functionally an education-services and assessments business. Quality is above sector average (high recurring revenue in K12 Virtual Learning and Vocational Qualifications; VUE has network effects) with a much cleaner balance sheet than legacy media peers. Listed peers include RELX (REL LN) — a better-managed data/analytics play; Wiley (WLY) — direct HE courseware peer, weaker growth; Chegg (CHGG) — a demonstrably AI-disrupted comparable that highlights the risk in the Pearson+ subscription thesis.

Investment thesis

• Assessments & Enterprise partnerships are a genuine AI-adjacent revenue line. Pearson VUE has secured Google Cloud certifications and "a new agreement with a leading AI lab to deliver their global certification programme"; Enterprise Solutions added Adobe, Salesforce and IBM as strategic partners, taking the ecosystem to 10, with 18% underlying adj-op-profit growth in H1 2026 2026-07 H1 results; 2026-01 FY25 trading update.
• Operating leverage is now visible. H1 2026 revenue +4% underlying delivered adjusted operating profit +14% and 140bps margin expansion; medium-term guidance is for 40bps average annual margin gain 2026-07 H1 results. The 2025 £87m product-development impairment removes ~£15m of annual amortisation for the next six years in Higher Education.
• Capital returns and balance-sheet quality. £350m buyback completed in H1 2026 at avg 998p (below current price), £350m 10-yr bond issued to term out debt, dividend +5%, and a £506m UK pension surplus (~50% in buy-in contracts) 2026-07 H1 results.

Key risks

• PTE / English Language Learning is deteriorating. Revenue -3% in H1 2026 with volumes -3%; management explicitly expects "market headwinds to persist in the near term" from tight migration policies 2026-07 H1 results. This was a high-margin growth engine.
• US Higher Education courseware is structurally fragile. International HE revenue declined in H1 2026; the US business is in a slow shift from print to Inclusive Access (now 50% of core US courseware) — the revenue-per-student trend is negative even if unit share holds. Generative AI is a demonstrable substitution risk for study-help products (see Chegg) 2026-07 H1 results; 2025-08 H1 results.
• US Student Assessment contract concentration. The New Jersey contract loss is a visible headwind through 2026; state contracts are lumpy and periodically re-tendered 2026-07 H1 results.

Operating leverage

Pearson has moderate-to-good operating leverage but not the pure-software profile the strategy prefers. H1 2026 gross margin was 51.2% (£910m / £1,779m) with operating expenses of £657m — most costs are fixed content development, platform, and central overhead that don't scale with incremental revenue. The 2026 half delivered a 3.5x profit-to-revenue growth ratio (+14% profit on +4% revenue), and management guides to sustained ~40bps annual margin expansion on mid-single-digit revenue. On a 10-20% revenue upside surprise, incremental contribution would plausibly land at 30–40% and add ~£100-150m to operating profit (roughly +15-25% profit uplift) — meaningful but not multiplicative. The Virtual Learning segment shows the best leverage (revenue +19%, profit +31% in H1 2026) driven by enrolment upside against a fixed school-network cost base 2026-07 H1 results.

Value-trap signals

None identified as terminal, but two watch-items: (i) PTE decline may not reverse if immigration policy stays restrictive; (ii) US courseware secular decline in print-per-student. These are managed decline stories, not value traps at current growth mix.

Earnings vs. expectations

Across the five-year filing window, Pearson has moved from repeated misses (2022 restructuring era) to consistent meet-or-beats: FY23 guidance was upgraded at the Q3 trading update (adj-op-profit range raised to £570-575m from £552m consensus); FY24 delivered in line with upgraded expectations; FY25 delivered £614m adj-op-profit at the top end of range with FCF conversion "in excess of 100%" plus State Aid recovery; H1 2026 exceeded expectations enough for management to reiterate full-year guidance early. Pattern: modest, credible beats with disciplined communication.

Conviction

4 — high. Anchoring factors: (i) clean audited disclosure with detailed segmental data; (ii) FY26 guidance is narrow and management has a track record of delivering it; (iii) multiple valuation methods converge in the 1,150-1,400p range. Limiting factors: PTE and US HE trajectory injects genuine forecasting uncertainty into the medium term; the AI-substitution risk to study-help products is real and unquantifiable from current disclosure.